Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health | FMCG | Executive
         
Latest Jobs

Kent
20 June 2013 12:50



Hampshire
20 June 2013 12:42



Norfolk & Cambridgeshire
20 June 2013 12:42


Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Mark Denton
Managing Director
markd@zenopa.com
+44 1494 818 049

Testimonials
Just wanted to say a huge thank you for all of the help and advice you gave me in the build up to my 2 interviews and ultimate success in gaining employment in my new role.
Julie, 2013

Johnson and Johnson pump research reports acne distress

28 May 2008 00:00 in Medical Company Product News


The impact of acne of adults who continue to suffer from it is significant, a report suggests.

A study conducted on behalf of Johnson & Johnson (J&J), makers of the Retin-A Micro Pump, reveals nearly half of dermatologists' patients are adults.

The effects of acne on adult lifestyles indicate it is stressful, inhibits social interaction and could curtail career progression, the Skin Matters survey said.

Richard Fried, clinical director at Yardley Dermatology and Yardley Skin Enhancement and Wellness Centre, author of Healing Adult Can, said acne is "definitely not just a teen issue".

"It has become increasingly common for adults to experience acne - one in five women who suffer from acne is between the ages of 25 and 40."

He added that the emotions experienced by the onset of adult acne could also make the problem worse but people's reactions to their acne varied.

J&J's Retin-A Micro is a topical prescription treatment that promises to start clearing up skin within two weeks with full results after seven weeks.

Other news stories from 28/05/2008

Recent news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Adfero News Agency



             
© Copyright 2013 Zenopa Ltd